Warning: This security is no longer trading.
defunct
Momenta Pharmaceuticals, Inc. (MNTA): Price and Financial Metrics
MNTA Price/Volume Stats
| Current price | $52.48 | 52-week high | $52.53 |
| Prev. close | $52.49 | 52-week low | $12.21 |
| Day low | $52.46 | Volume | 8,010,600 |
| Day high | $52.53 | Avg. volume | 1,939,894 |
| 50-day MA | $43.52 | Dividend yield | N/A |
| 200-day MA | $32.97 | Market Cap | 6.25B |
MNTA Stock Price Chart Interactive Chart >
Momenta Pharmaceuticals, Inc. (MNTA) Company Bio
Momenta Pharmaceuticals is specializing in the detailed structural analysis of complex drugs and applying its technology to the development of generic versions of complex drugs, biosimilar and potentially interchangeable biologics, and to the discovery and development of novel therapeutics for oncology and autoimmune indications. The company was founded in 2001 and is based in Cambridge, Massachusetts.
MNTA Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | 166.94% |
| YTD | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | 0.00% |
| 2019 | 78.71% |
Continue Researching MNTA
Want to see what other sources are saying about Momenta Pharmaceuticals Inc's financials and stock price? Try the links below:Momenta Pharmaceuticals Inc (MNTA) Stock Price | Nasdaq
Momenta Pharmaceuticals Inc (MNTA) Stock Quote, History and News - Yahoo Finance
Momenta Pharmaceuticals Inc (MNTA) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...